January 16, 2018 / 7:32 AM / in 3 months

BRIEF-Midatech Pharma Says Approval Of Investigational New Drug Application From US FDA To Conduct Study Of MTX110

Jan 16 (Reuters) - Midatech Pharma Plc:

* APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FROM US FDA TO CONDUCT A STUDY OF MTX110

* MTX110 IS AN INVESTIGATIONAL NANO-INCLUSION PRODUCT, FOR TREATMENT OF FATAL CHILDHOOD BRAIN CANCER DIPG Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below